NYSEARCA:PSIL AdvisorShares Psychedelics ETF (PSIL) Price, Holdings, & News → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free PSIL Stock Alerts $1.19 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share Today's Range$1.18▼$1.2050-Day Range$1.19▼$1.5452-Week Range$1.17▼$2.25Volume22,079 shsAverage Volume65,943 shsMarket Capitalization$6.69 millionAssets Under Management$6.54 millionDividend Yield4.20%Net Expense Ratio1.00% Stock AnalysisStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Get AdvisorShares Psychedelics ETF alerts: Email Address About AdvisorShares Psychedelics ETF (NYSEARCA:PSIL)The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.Read More PSIL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PSIL ETF News HeadlinesFebruary 13, 2024 | thestreet.comAdvisorShares Psychedelics ETFDecember 18, 2023 | markets.businessinsider.comPsyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And MoreSeptember 11, 2023 | markets.businessinsider.comPsyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And MoreAugust 21, 2023 | benzinga.comPsyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly ReportsJuly 24, 2023 | benzinga.comPsyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & MoreJuly 15, 2023 | msn.comWatch these psychedelic stocks as sector faces year of 'collapse and consolidation'July 11, 2023 | markets.businessinsider.comPsyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And MoreMay 15, 2023 | markets.businessinsider.comPsyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & MoreSee More Headlines Receive PSIL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AdvisorShares Psychedelics ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerAdvisorShares Fund NameAdvisorShares Psychedelics ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PSIL Inception Date9/15/2021 Fund ManagerDan S. Ahrens WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings28 Fund Statistics Assets Under Management$6.54 million Average Daily Volume$0.00 Discount/Premium0.03% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorAdvisorShares Investments, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume10 Put Options265 Call Options10 Miscellaneous Outstanding Shares5,620,000Beta0.87 Creation Fee$500.00 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Ad Porter & CompanyThe only financial event in 2024 that matters Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here AdvisorShares Psychedelics ETF ExpensesTypePSILTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.60%0.57%0.54%0.51%0.51%Other Expenses2.51%0.72%0.54%0.64%0.58%Total Expense3.11%0.72%0.70%0.74%0.70%Fee Waiver-2.11%-0.76%-0.55%-0.68%-0.56%Net Expense1.00%0.59%0.60%0.58%0.58% AdvisorShares Psychedelics ETF (PSIL) Holdings & ExposureTop 10 PSIL HoldingsMind Medicine (MindMed)(NASDAQ:MNMD)Holding Weight: 16.20%Cybin Inc Ordinary SharesHolding Weight: 9.66%COMPASS Pathways(NASDAQ:CMPS)Holding Weight: 6.69%BlackRock Liquidity Treasury InstlHolding Weight: 5.95%GH Research(NASDAQ:GHRS)Holding Weight: 5.61%NRx Pharmaceuticals(NASDAQ:NRXP)Holding Weight: 5.35%Atai Life Sciences(NASDAQ:ATAI)Holding Weight: 5.14%Intra-Cellular Therapies(NASDAQ:ITCI)Holding Weight: 5.00%Vistagen Therapeutics(NASDAQ:VTGN)Holding Weight: 4.71%Alkermes(NASDAQ:ALKS)Holding Weight: 4.69%PSIL Sector ExposurePSIL Industry ExposureFull Holdings Details Similar ETFsIQ Global Equity R&D Leaders ETFNASDAQ:WRNDiShares Future Metaverse Tech and Communications ETFNYSEARCA:IVRSGrayscale Future of Finance ETFNYSEARCA:GFOFETFB Green SRI REITs ETFNYSEARCA:RITAGlobal X Disruptive Materials ETFNASDAQ:DMATInstitutional OwnershipSpire Wealth ManagementBought 18,000 shares on 4/24/2024Ownership: 0.773%View All Institutional Transactions PSIL ETF - Frequently Asked Questions How have PSIL shares performed in 2024? AdvisorShares Psychedelics ETF's stock was trading at $1.39 at the start of the year. Since then, PSIL stock has decreased by 14.4% and is now trading at $1.19. View the best growth stocks for 2024 here. What does PSIL invest in? AdvisorShares Psychedelics ETF is a equity fund issued by AdvisorShares. PSIL focuses on theme investments. The fund's investments total to approximately $6.54 million assets under management. What stocks does AdvisorShares Psychedelics ETF hold? PSIL invests in 28 holdings. Some of the stocks in their portfolio include Mind Medicine (MindMed) (MNMD), COMPASS Pathways (CMPS), GH Research (GHRS), NRx Pharmaceuticals (NRXP), Atai Life Sciences (ATAI), Intra-Cellular Therapies (ITCI), Vistagen Therapeutics (VTGN), Alkermes (ALKS), Psyence Biomedical (PBM) and Relmada Therapeutics (RLMD). What is the management fee for AdvisorShares Psychedelics ETF? AdvisorShares Psychedelics ETF's management fee is 0.60% and has other expenses of 2.51%. However, PSIL has a fee waiver of -2.11% to reimburse the expenses. The net expense ratio for PSIL is 1.00%. Who are AdvisorShares Psychedelics ETF's major shareholders? AdvisorShares Psychedelics ETF's stock is owned by many different retail and institutional investors. Top institutional shareholders include Spire Wealth Management (0.77%). How do I buy shares of AdvisorShares Psychedelics ETF? Shares of PSIL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:PSIL) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.